Axonics Inc (AXNX) - News Archive

Showing 3 of 3 results.

Axonics Receives Regulatory Approval for Fourth-Generation Rechargeable SNM System in Australia,

Axonics Secures Regulatory Approval for Advanced Fourth-Generation Rechargeable SNM System in Australia Irvine, Calif. October 9, 2023 Axonics, Inc. (Nasdaq: AXNX), a global leader in the development of innovative thera...

Sep 26, 2024 • Medical Equipment & Supplies Industry Business Update Nasdaq

Axonics' Groundbreaking Recharge-Free SNM System Gains Regulatory Approval in Australia, Offering Relief for Overactive Bladder

Axonics Receives Regulatory Approval for Game-Changing Sacral Neuromodulation System in AustraliaIn a groundbreaking move for the medical field, Axonics, Inc. has announced that its recharge-free sacral neuromodulation...

May 17, 2024 • Medical Equipment & Supplies Industry Business Update Nasdaq

Axonics Unleashes Revolutionary Recharge-Free SNM System to Transform Overactive Bladder Treatment in Australia

Axonics Revolutionizes Overactive Bladder Treatment with Recharge-Free SNM System Now Available in AustraliaIn a significant breakthrough for Australians plagued by bladder and bowel dysfunction, Axonics, Inc. (Nasdaq:...

May 16, 2024 • Medical Equipment & Supplies Industry Business Update Nasdaq